Skip to main content

Table 3 Comparison of laboratory parameters between treatment groups during the study

From: Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trial

Variable Group Pre-test Post-test p value Within-group p value
Blood glucose (mg/dl) Intervention group 112.56 ± 8.31 109.54 ± 8.69 0.23 p = .005
Comparison group 112.9 ± 8.65 107.70 ± 10.81 p = .001
Between-group p value 0.84 0.35  
Total cholesterol (mg/dl) Intervention group 209.48 ± 14.42 180.68 ± 14.51 0.71 p < .001
Comparison group 206.28 ± 6.61 180.12 ± 7.50 p < .001
Between-group p value 0.157 0.809  
Triglyceride (mg/dl) Intervention group 148.22 ± 18.52 110.06 ± 19.35 0.73 p < .001
Comparison group 145.98 ± 19.88 106 ± 13.96 p < .001
Between-group p value 0.56 0.23  
HDL (mg/dl) Intervention group 46.46 ± 4.01 48.98 ± 4.32 0.48 p < .001
Comparison group 46.50 ± 6.90 49.58 ± 6.63 p < .001
Between-group p value 0.97 0.59  
LDL (mg/dl) Intervention group 133.94 ± 4.85 111.42 ± 6.37 0.1 p < .001
Comparison group 132.52 ± 3.44 111.26 ± 10.67 p < .001
Between-group p value 0.09 0.92  
AST (mg/dl) Intervention group 44.14 ± 16.67 37.72 ± 8.45 0.06 p = .026
Comparison group 43.52 ± 11.52 41.06 ± 8.42 p = .036
Between-group p value 0.83 0.051  
ALT (mg/dl) Intervention group 64.02 ± 22.26 48.12 ± 11.52 0.012 p < .001
Comparison group 59.60 ± 19.07 53.52 ± 14.02 p < .001
Between-group p value 0.28 0.038  
  1. LDL low-density lipoprotein, HDL high-density lipoproteins, ALT alanine aminotransferase, AST aspartate aminotransferase